Conclusion
Our study indicates that a single screening ultrasound of temporal and axillary arteries accurately identified 83.3% of patients with subclinical GCA in an inception PMR cohort. Our experience indicates these patients are likely to be resistant to PMR-dose steroids and may ultimately require biologic therapy.
The Study Abstract
Presented at ACR Convergence 2022
Kirby C, Flood R, Mullan R, Murphy G, Kane D. Sonographic prevalence of subclinical GCA in newly diagnosed PMR [abstract]. Arthritis Rheumatol. 2022;74(suppl 9).
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Disclosures
C. Kirby, none; R. Flood, none; R. Mullan, none; G. Murphy, AbbVie/Abbott; D. Kane, AbbVie/Abbott.